Loading clinical trials...
Loading clinical trials...
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology Subtitle: Pathological Myeloid Activation After Sepsis and Trauma
Conditions
Interventions
Blood sampling
Locations
1
United States
UF Health at Shands hospital
Gainesville, Florida, United States
Start Date
January 4, 2022
Primary Completion Date
July 1, 2026
Completion Date
April 1, 2027
Last Updated
December 26, 2025
NCT06712641
NCT07533994
NCT07367113
NCT07356583
NCT06517810
NCT07172451
Lead Sponsor
University of Florida
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions